Search

everythinglearnresearchcommunity

for

Search:↓

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Nivolumab can cause hair loss as a rare side effect.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Lower adiponectin levels are linked to higher insulin resistance in women with PCOS.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

The document concludes that non-endocrine alopecia in pets varies in treatment effectiveness and often has a poor prognosis, especially in cats.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Phytochemicals from plants may help improve hormonal health naturally.

Adipose tissue changes in obesity can trigger stress in fat cells.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.